KEITH WEBSTER to Neovascularization, Physiologic
This is a "connection" page, showing publications KEITH WEBSTER has written about Neovascularization, Physiologic.
Connection Strength
0.430
-
Vascular Regeneration in Ischemic Hindlimb by Adeno-Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor. J Am Heart Assoc. 2016 05 26; 5(6).
Score: 0.115
-
Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration. J Cell Mol Med. 2011 Oct; 15(10):2046-56.
Score: 0.083
-
Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther. 2005 May; 12(9):762-71.
Score: 0.053
-
Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies. Int J Mol Sci. 2021 May 01; 22(9).
Score: 0.040
-
Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease. Angiogenesis. 2017 Nov; 20(4):479-492.
Score: 0.031
-
Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells. Arterioscler Thromb Vasc Biol. 2016 Apr; 36(4):663-672.
Score: 0.028
-
Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis. Stem Cells. 2015 Jun; 33(6):1850-1862.
Score: 0.027
-
Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor. PLoS One. 2015; 10(5):e0127904.
Score: 0.027
-
Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning. Stem Cells. 2014 Oct; 32(10):2702-13.
Score: 0.026